Award

Roswell Park Cancer Center Support Grant

Description: Roswell Park Comprehensive Cancer Center is one of only a small number of freestanding, NCI-designated, comprehensive cancer centers, and the only comprehensive center in New York State (NYS) outside of Manhattan. Roswell Park has a rich history of leadership in basic discovery, translational, clinical and population-based science in cancer research. In recent years Roswell Park has pushed the boundaries of excellence in cancer research and has experienced exponential growth in faculty recruitment, programmatic and scientific excellence, a robust clinical trial portfolio and accrual to investigator-initiated trials, population cancer science development and a broader footprint in the WNY catchment area and community. We propose here to be a leader in the development of innovative approaches in cancer research to improve the quality of care for our patients in our catchment area and beyond, to enhance collaborative efforts between scientists and physicians toward a more effective translation of our discoveries into paradigm changing patient practices and interventions and policies, to train and develop the next generation of investigators through innovative oncology-focused programs, to focus on the needs of our catchment area of WNY relevant to our cancer burden through research and outreach using effective strategies for education, prevention, treatment and survivorship and to cultivate, value and promote fairness, accountability, integrity and respect across our cancer center employees, scientists, physicians, nurses and healthcare staff, students and trainees and leadership toward a more productive workplace and to serve our community more effectively. Roswell Park continues to play a primary role in discovery and innovation that enable us to deliver the best cancer care to our patients in New York State, around the country and around the world.
Funding type: program
Funder scheme: P30
Start date: 1978-06-01
End date: 2029-04-30
Investigator: CANDACE S JOHNSON
Institution: ROSWELL PARK CANCER INSTITUTE CORP
Funded outputs count: 3,904
Funder award ID: P30CA016056
OpenAlex ID: G9000888465
2026 · Sarah Athans, Meegan Young, et al. · bioRxiv (Cold Spring Harbor Laboratory)
2026 · Bhavisha Doshi, Eduardo Cortes Gomez, et al. · bioRxiv (Cold Spring Harbor Laboratory)
2026 · Vishnu Kumarasamy, Jianxin Wang, et al. · Cancer Research · 2
2026 · Johnny Cruz-Corchado, Veena Prahlad · Philosophical Transactions of the Royal Society B Biological Sciences
2026 · Eslam A. Elsaedy, Tamrah AlRammah, et al. · Annals of Surgical Oncology
2026 · Nicholas J Salgia, Adil Khan, et al. · Journal for ImmunoTherapy of Cancer
2026 · Brian Christopher Betts, Constanza Savid-Frontera, et al. · Journal for ImmunoTherapy of Cancer
2026 · Qin Yang, Miguel Torres-Martin, et al. · Journal of Clinical Investigation
2026 · Sae Bom Lee, Allan Pavy, et al. · Nature Communications · 5
2026 · Tianmou Liu, Han Yu, et al. · Journal of Applied Statistics
2026 · Clark Zhang, Xiaoyi Ma, et al. · Frontiers in Gastroenterology
2026 · Loïs A.K. van der Pluijm, Angela Koudijs, et al. · Molecular Therapy — Nucleic Acids
Year
Topic